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The incidence of complications secondary to fracture stabilization, particularly osteolytic 
lesions and bony tumor formation, has long been difficult to evaluate. The objective of this 
study was to describe the long-term incidence of aggressive bony changes developing 
in dogs with long bone diaphyseal fractures stabilized by metallic bone plates compared 
to a breed-, sex-, and age-matched control group. The medical records of a tertiary 
referral center were retrospectively reviewed for dogs that matched each respective cri-
terion. Signalment, history, cause of death (if applicable), and aggressive bony changes 
at previous fracture sites were recorded. Ninety dogs met the criteria for inclusion in the 
fracture group and were matched with appropriate control dogs. Four of the dogs in 
the fracture group developed aggressive bony changes at the site of previous fracture 
repairs most consistent with osseous neoplasia. One lesion was confirmed with cytology 
as neoplastic. The population of dogs was mixed with regard to breed and body weight, 
but all dogs with aggressive bony lesions were male. Incidence of aggressive bony lesion 
formation in the fracture group was 4 (4.4%) and was 0 (0%) in the control group; three 
(75%) of the affected dogs in the fracture group included cerclage as a component of 
their primary fracture stabilizations. Incidence of aggressive bony lesions in the fracture 
group compared to the control group was determined to be statistically significant 
(p =  0.0455), as was the incidence of cerclage among dogs affected by aggressive 
bony lesions compared to the rest of the fracture group (p = 0.0499). Development of 
aggressive bony lesions is an uncommon complication of fracture fixation. Additional 
research is needed to further identify and elucidate the long-term effects of metallic 
implants in dogs.
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inTrODUcTiOn
Premalignant inflammatory changes and tumor formation in 
association with metallic hardware and fracture stabilization are 
a well-recognized, though uncommonly reported, occurrence 
in veterinary and human patients (1–3). Implant or fracture-
associated tumors are neoplasms that develop in close proximity 
to a previous fracture or implant, develop after a considerable 
time delay between the inciting injury and implant placement, 
and lack other known predisposing factors in the vicinity includ-
ing chronic infection or prior radiotherapy (2, 4–6). Previous 
reports of dogs afflicted with implant or fracture-associated 
tumors have identified primarily older patients, with an implant-
to-tumor formation time range from 1 to 12  years (2, 4–6). 
Osteosarcoma is the most commonly identified tumor type (2, 6, 
7). Implant- or fracture-associated osteosarcomas have distinctly 
different biological behavior compared to spontaneously forming 
osteosarcomas, as they are primarily reported to arise from the 
diaphyseal region of long bones rather than the metaphyses and 
are predominantly found in the femur and tibia rather than the 
radius or humerus (1, 2, 6, 8, 9).
Multiple mechanisms have been hypothesized to contribute to 
the formation of implant- or fracture-associated sarcomas, includ-
ing sensitization of the patient to metallic implants, implant cor-
rosion, genomic instability induced by prolonged metal exposure, 
delayed fracture unions, and healing of the fracture itself. Chronic 
tissue irritation secondary to low-grade infection has been shown 
to promote spontaneous tumorigenesis (10–20). Even with all of 
the potential risk factors, metallic implant-associated neoplasms 
in people are recognized as a rarity. The purpose of this study was 
to determine the incidence of aggressive bony lesions that may 
be implant-associated tumors in a population of dogs following 
open reduction and repair of long bone, diaphyseal fractures with 
metallic bone plates. Our hypothesis was that there would be a 
significantly higher incidence of aggressive bony lesions in dogs 
with fractures repaired with plates compared to a case-matched 
control group.
MaTerials anD MeThODs
The medical records available for review of dogs presenting with 
long bone fractures to a tertiary referral center from January 1, 
2000 to April 1, 2014 were retrospectively evaluated. Cases were 
reviewed and dogs were selected based on method of fracture 
repair (open reduction and internal fixation using bone plates and 
screws) and fracture location (diaphyseal fractures). Exclusion 
criteria included non-diaphyseal fractures, amputation of the 
repaired limb less than 1 year after internal fixation, removal of 
the bone plate less than 1 year after internal fixation, pre-existing 
malignant neoplasia, fracture fixation-to-lesion interval of equal 
to or less than 1 year, or follow-up of less than 1 year. The time 
delay from implant placement to lesion formation was selected 
based on previous veterinary reports of implant-associated 
neoplasm formation as soon as 1  year after internal fracture 
stabilization (8, 20). Information obtained from medical records 
and phone interviews with the owners or referring veterinarians 
included signalment, history, comorbidities, fracture location, 
method of fracture fixation, and cause of death (if applicable). 
The medical records and radiographs of dogs identified with 
aggressive bony lesions more than a year postfixation at the prior 
fracture sites were reviewed by a board-certified veterinary radi-
ologist. Radiographic findings consistent with aggressive disease 
include cortical destruction (which can include the presence of 
geographic, moth-eaten, or permeative lysis), presence of active 
periosteal proliferation (i.e., palisading, speculated, or amorphous 
new bone), and a longer zone of transition between normal and 
abnormal bone (21). Cytologic confirmation of aggressive bony 
lesions was recorded when available. All dogs that met the criteria 
to be included in the fracture group were compared to breed-, 
sex-, and age-matched controls from the same tertiary referral 
center with comparable follow-up information.
The primary outcome for statistical analysis of the fracture 
group was aggressive bony lesion formation. Incidence of 
aggressive bony lesions was compared between cases and age-, 
breed-, and sex-matched controls using McNemar’s chi-square 
test (because two cells in the 2 by 2 table had 0 counts, a small 
constant of 0.0001 was added to all four cells). Association 
between prognostic factors and development of aggressive 
bony lesions was assessed among dogs that underwent fracture 
repair (90 cases). Continuous prognostic factors were age at 
time of fracture repair and body weight, while categorical prog-
nostic factors included gender, neuter status, breed, cerclage, 
non-cerclage metallic implants (not associated with securing 
the bone plate), non-metallic implants, bone, and side of body 
operated (right or left). Contingency tables were generated for 
the categorical factors. Association between aggressive bony 
lesion development and each of the continuous variables was 
assessed using the exact Wilcoxon rank-sum test. Associations 
between aggressive bony lesion development and each categori-
cal factor were assessed with the Fisher’s exact test. Statistical 
significance was set to p < 0.05. All analyses were performed 
using SAS version 9.4 (Cary, NC, USA). Multivariable mod-
eling was not successful due to the limited number of dogs with 
bony lesion formation. This limitation led to quasi-separation 
of data.
resUlTs
Of the 231 patients with long bone fractures reviewed, postopera-
tive history and outcome or cause of death could be determined 
in 90 dogs. Median age and weight at the time of fracture were 
22 months (range 1–160 months) and 12.3 kg (range 1.2–46.4 kg), 
respectively. The most frequently represented breeds were the 
mixed breed, Labrador retriever, German Shepherd Dog, and 
Chihuahua (n = 25, 6, 5, and 4). Forty-four of the dogs were male 
(20 intact, 24 castrated), and 46 were female (14 intact, 32 spayed). 
Median age at the date of last follow-up was 105 months (range 
31–286  months). Each of the dogs in the fracture group was 
matched to a control dog of the same breed, sex, and comparable 
age (within 12 months) at the time of last follow-up. Forty-four of 
the dogs were male (11 intact, 33 castrated), and 46 were female 
(8 intact, 38 spayed). The median weight and age of the dogs in 
the control group at the time of last follow-up were 17.6 kg (range 
0.8–68 kg) and 108 months (range 17–244 months), respectively.
TaBle 1 | signalment, age at time of fracture repair (aaF), age at lesion diagnosis (aaD), surgery-lesion interval (sli), and bone affected of dogs that 
developed implant-associated lesions.
Patient Breed sex Weight (kg) aaF (months) aaD (months) sli (months) Bone
Case 1 German Shepherd Dog MN 36.4 71 101 30 Humerus
Case 2 Standard Poodle MN 20 18 126 108 Tibia
Case 3 Mixed breed MN 30.1 146 177 31 Femur
Case 4 Miniature Schnauzer MN 11.1 28 91 63 Femur
MN, male neutered.
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Among the 90 cases in the fracture group with known outcome, 
90 long bone, diaphyseal fractures repaired with metallic plates 
were identified. The radius was most frequently represented (42), 
followed by the femur (22), tibia (22), and humerus (4). Fifty-five 
fractures (61%) were repaired with bone plates alone, while 35 
(39%) had additional implants, including cerclage (22, 24%), 
non-cerclage metallic implants (25, 28%), and non-metallic 
prosthetics (1, 1%).
Four of the patients in the fracture group with follow-up 
(4.4%) developed aggressive bony changes at previous fracture 
sites and ultimately were euthanized due to progression of clinical 
signs (Table 1). All of these patients presented with non-weight-
bearing lameness and swelling with marked pain at the site of 
the bony lesions. Among the remaining 86 dogs, 63 were alive 
at inquiry; the other 23 dogs had either died or been euthanized 
for reasons unrelated to their fracture repairs. All dogs with sus-
pected tumors were neutered males, with a median body weight 
of 25.1 kg. Median age of the dogs at the time of suspected tumor 
diagnosis was 113.5  months (range 91–177  months); median 
interval between fracture fixation and suspected tumor formation 
was 47 months (range 30–108 months). Three of the four dogs 
had additional implants in combination with the primary bone 
plate (three cerclage, one non-cerclage metallic implant). None 
of the patients in the control group developed clinically apparent 
lameness requiring radiographic evaluation or bone pain.
All dogs with bone lesions were confirmed to have radiographic 
signs consistent with aggressive disease. Radiographic findings in 
the affected dogs included moth-eaten and permeative osteolysis, 
primarily spiculated and amorphous periosteal proliferation, and 
circumferential soft tissue swelling all centered at the level of the 
implant (Figure 1). Aggressive changes were noted (n = 2) at the 
proximal aspect of the plate and the rest (n = 2) at the distal aspect 
of the plate. Based on the extended length of time between fracture 
fixation and the formation of monostotic aggressive bone lesions, 
implant-associated neoplasia was considered the top differential. 
Other possible differentials included naturally occurring primary 
osseous neoplasia, fungal osteomyelitis, and metastatic neoplasia. 
Of the four cases with osteolysis, one lesion was confirmed to be 
a sarcoma compatible with osteosarcoma by cytology. Cytologic 
confirmation was not available for three cases.
Variables analyzed for their effect on bony lesion formation 
within the fracture group included age at the time of fracture 
repair, body weight, neuter status, breed, cerclage, non-cerclage 
metallic implants, non-metallic implants, bone affected, and side 
of the body operated. Of those factors, only the presence of cer-
clage was found to be statistically significant. Table 2 lists p-values 
for all analyzed variables. When comparing the incidence of bony 
lesion formation in the fracture group to the incidence in the con-
trol group, the difference was found to be statistically significant 
(p = 0.0455).
DiscUssiOn
Due to the incidence of spontaneous osteosarcoma in dogs, much 
of the debate regarding fracture-associated tumors centers on 
whether such tumors are coincidental events. The results of this 
study indicate a greater than expected incidence (4.4%) of late 
aggressive bony lesion development in dogs that have undergone 
internal fixation of diaphyseal long bone fractures with bone 
plates. Based on the data of this study combined with recent 
reports from veterinary literature, the authors believe that the 
number of dogs developing late bony lesions at sites of previous 
fracture repair is significant and has the potential to represent 
a unique entity. A similar relationship has been reported for 
implant-associated neoplasia and may be applicable to the one 
case with a diagnosis of neoplasia in our study (2, 6).
The affected dogs of this report were four neutered males, and 
two of the dogs represented were greater than 30 kg. Male dogs 
were exclusively affected in this study, but it should be noted that in 
two recent studies of fracture-associated and implant-associated 
neoplasia either female dogs were overrepresented or the sexes 
were equally affected (2, 9). Due to the low number of affected 
dogs in this report any sex predispositions cannot be evaluated. 
Previous reports of both implant-associated neoplasia and spon-
taneous osteosarcoma have shown predispositions for large to 
giant breed dogs, which was supported by our findings (1, 2, 9). It 
is, however, interesting to note that the smallest dog represented 
weighed only 11.1  kg and was a miniature Schnauzer, a breed 
not generally considered to be at increased risk of spontaneously 
developing osseous neoplasia. In one study, 4 out of 10 dogs with 
previously documented medullary bone infarcts that developed 
spontaneous osteosarcomas were miniature Schnauzers (7). No 
bone infarcts were documented to have formed in the miniature 
Schnauzer of this report. Median time from fracture stabiliza-
tion to diagnosis of disease was 47 months (1,410 days), with the 
earliest bony lesion formation noted at 30 months (900 days) and 
the latest lesion formation noted at 108 months (3,240 days). A 
definitive diagnosis of neoplasia was achieved in only one patient 
of this report. However, it is worth noting that the affected dogs 
in this study have a time interval to lesion diagnosis comparable 
to a recent study of fracture-associated sarcomas in dogs, which 
reported fracture-associated sarcoma development between 
TaBle 2 | association between prognostic factors and bony lesion 
formation—fracture group.
Prognostic factor p-Value
Gender 0.0531
Neuter status 0.293
Breed 0.4308
Cerclage 0.0499a
Non-cerclage metallic implants 1
Non-metallic prosthetics 1
Bone 0.0775
Side operated 0.6657
Body weight (kg) 0.0862
Age at fracture repair (months) 0.1426
aStatistically significant.
FigUre 1 | craniocaudal radiograph of the femur. (a) This image was 
acquired immediately postfracture fixation. (B) This image was acquired 
2 years later. There is now moth-eaten lysis of the proximal to mid diaphysis 
of the femur in addition to cortical thinning medially. Spiculated and 
amorphous periosteal proliferation is present medially and laterally, but is best 
observed lateral to the compression plate.
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1,348 and 3,488 days (9). The most commonly affected site in the 
patients of this report was the femur, consistent with a previous 
report identifying 12/13 dogs affected with histologically con-
firmed fracture-associated neoplasia occurring in the femur (9). 
Osteolytic lesion formation in all dogs in this study was believed 
to originate at the diaphysis, also consistent with a previous report 
of implant-associated neoplasia (2). While cytologic confirma-
tion of neoplasia was achieved in one case; the remaining cases 
had radiographic changes strongly suggestive of a neoplastic 
process. However, other pathologic processes cannot be ruled 
out, including fungal disease.
Another interesting discovery was that three of the four dogs 
with aggressive bony lesion formation had additional metallic 
internal fixation (cerclage). This variable was found to be statisti-
cally significant (p =  0.0499) and was an unexpected finding. 
Due to the low number of dogs identified with aggressive bony 
lesions, this finding should be interpreted with some caution. 
While chronic irritation, inflammation, or infection has not been 
directly linked with implant-associated neoplasia, other tumors 
have been reported to form in association with these conditions 
(11, 15, 16). Thus, a similar relationship may be responsible for 
the lesions seen in the present study. Considering this, the authors 
speculate that if cerclage wire is not tightened optimally, or loos-
ens over time, it may create chronic irritation and inflammation 
from micromotion, or infection; this may have contributed to the 
formation of the lesions seen. However, the reasons for the sig-
nificant effect of cerclage wire are unknown and the occurrence 
of the lesions when cerclage was used may simply be coincidental.
Many hypotheses exist regarding the pathogenesis of 
implant-associated sarcomas. It has been proposed that implant 
corrosion and wear debris contribute a direct mutagenic effect 
to surrounding tissues (22). In support of this hypothesis, mul-
tiple studies have demonstrated that metallic implants are not 
biologically inert or categorically benign. Several metals, such as 
beryllium, cadmium, chromium, cobalt, and nickel, have been 
recognized as carcinogenic and metallic corrosion products 
have been identified locally in both animals and people (13, 
17, 18, 23–25). Chromosomal aberrations have been found in 
human cells exposed to metallic corrosion and wear debris, and 
corrosion debris has also been found in veterinary and human 
patients with implant-associated tumors (13, 18, 22, 24, 26). In 
addition, laboratory animals exposed to metals used in metallic 
implants have developed tumors associated with the implant 
sites (8, 27).
While the lesion in one case was documented as neoplastic, 
it is not known if the plates used for the patients in this study 
contributed to the formation of the lesions seen. The plates used 
were all of 316L stainless steel and conformed to ASTM F138, 
Standard for Stainless Steel Bar and Wire for Surgical Implants 
(28). This is the present standard and was in effect during manu-
facture of all the plates used in this study. Thus, no differences 
in the composition of plates over the study period or the time 
surgery was performed can account for the occurrence of lesions 
observed. The use of dissimilar metals at the same fracture site, 
either from a lack of plate homogeneity or metallic composi-
tion differences between the plate and other implants, has been 
reported to increase the rate of plate corrosion (14, 23). However, 
a definitive mechanism for this increase was not clearly identi-
fied in these reports. As with the plates in this study, the cerclage 
wire used also was 316L stainless steel and conformed to ASTM 
F138 as a standard. While the metal for cerclage wire is worked 
to provide different mechanical properties, the specifications for 
the 316L stainless steel are the same. Considering this, different 
metals were not used and thus cannot account for the formation 
of the lesions observed.
Another hypothesis of the pathogenesis of implant-associated 
tumor formation focuses on the effects of chronic inflammation. 
Any factor that stimulates chronic inflammation may predispose 
patients to form tumors (11, 15, 16). Tissue sensitization has 
been documented in response to metallic implants in people 
(10, 12, 19). This hypersensitivity may be responsible for long-
term implant loosening and chronic osteomyelitis (19). Chronic 
osteomyelitis, either due to implant–tissue interactions or from 
other underlying disease, has been associated with tumor forma-
tion in canine and human patients. However, while recognized 
as a contributor to tumorigenesis, definitive proof that implant-
associated malignances are affected by long-term inflammation 
at the surgical site is not available (3, 16). Repetitive, low-grade 
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trauma, bone infarcts, and the healing processes associated with 
sustaining a fracture, have also been considered as potential pro-
moters of malignancy (7, 20, 29). Despite these findings, direct 
causal relationships are difficult to prove.
Limitations of this study include its retrospective design, a 
lack of tissue-based diagnosis for three dogs with radiographic 
evidence of aggressive bony disease at the site of previous fracture 
fixation that would support or confirm a neoplastic diagnosis, 
and the small sample population. Owner preference determined 
whether a definitive diagnosis was found for each case; for some 
owners, the cost and potential risks of bone biopsy or limb 
amputation were of enough concern that they chose not pursue 
a definitive diagnosis (30). In addition, all the dogs in this study 
that had bony lesions were non-weight-bearing lame and mark-
edly painful at the lesion site and this likely contributed to the 
decision for euthanasia by the owners. Although cytology was 
not available for most cases, implant-associated neoplasia was 
considered most likely because the bony changes were centered 
at the level of previous surgical stabilization and took at least 
2 years to form. However, because several cases lacked a tissue-
based diagnosis, naturally occurring neoplasia and fungal disease 
remain potential differentials for the aggressive lesions identified. 
Additionally, it should be noted that many cases were excluded 
from the study group due to lack of adequate follow-up. This may 
have influenced the incidence of aggressive bony lesions identified 
in this report. A recent study of fracture-associated neoplasms 
reported an incidence of 0.0008%, which is considerably lower 
than the incidence of dogs that developed aggressive bony lesions 
in this report (4.4%) (9). While aggressive bony lesions cannot 
be diagnosed as neoplasia without cytologic or histopathologic 
confirmation, the authors speculate that radiographic appearance 
of these lesions alone is sufficient for many general practitioners 
to make practical decisions regarding the care of affected dogs. 
Furthermore, since both recent studies evaluating fracture and 
implant-associated neoplasms did not have any follow-up with 
general practitioners or owners, and exclusively used an elec-
tronic records system to identify cases, additional dogs affected 
with neoplasia could have been missed (2, 9).
Our hypothesis that there would be a significantly higher 
incidence of aggressive bony lesions in dogs with fractures 
repaired with plates compared to a case-matched control group 
was supported in the present study. Thus, the authors consider 
the findings of this study to be highly suggestive of a causal 
relationship between fractures stabilized with metallic implants 
and the development of aggressive bony lesions. Open reduction 
with internal stabilization is considered the treatment of choice 
for many fractures encountered in veterinary medicine (31). 
The authors feel strongly that the benefits of implants greatly 
outweigh the risk of late aggressive bony lesion development. 
This risk, however, may be increased in male dogs or animals that 
have cerclage wire used, based on the results of this study. Despite 
this finding, the increase in risk found for either parameter also 
may have been coincidental. Interestingly, the only case with a 
cytologic diagnosis of neoplasia did not have cerclage wire used; 
thus no direct relationship with cerclage wire and neoplasia can 
be made. Other than standard indications (implant failure, infec-
tion, irritation, athletes, and young animals), we do not advocate 
routine retrieval of implants due to the associated risks of general 
anesthesia, postoperative morbidity, and refracture of the initial 
repair site. A prospective study for the lifetime of a large popula-
tion of dogs may provide the most accurate incidence of aggres-
sive bony lesion development after fracture repair with plates. 
A prospective study may also aid in identifying additional risk 
factors for lesion formation, such as breed, nature of initial injury, 
implant composition, and fracture-associated complications.
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